-
D651903-10mgDS-7423 is a dual PI3K and mTOR inhibitor, with IC 50 values of 15.6 nM, 34.9 nM for PI3Kα and mTOR , respectively. DS-7423 possesses anti-tumor activity.In VitroDS-7423 increases TP53 expression, the level of p-TP53 on Ser-46, and induced
-
D651903-1mgDS-7423 is a dual PI3K and mTOR inhibitor, with IC 50 values of 15.6 nM, 34.9 nM for PI3Kα and mTOR , respectively. DS-7423 possesses anti-tumor activity.In VitroDS-7423 increases TP53 expression, the level of p-TP53 on Ser-46, and induced
-
D651903-25mgDS-7423 is a dual PI3K and mTOR inhibitor, with IC 50 values of 15.6 nM, 34.9 nM for PI3Kα and mTOR , respectively. DS-7423 possesses anti-tumor activity.In VitroDS-7423 increases TP53 expression, the level of p-TP53 on Ser-46, and induced
-
D651903-5mgDS-7423 is a dual PI3K and mTOR inhibitor, with IC 50 values of 15.6 nM, 34.9 nM for PI3Kα and mTOR , respectively. DS-7423 possesses anti-tumor activity.In VitroDS-7423 increases TP53 expression, the level of p-TP53 on Ser-46, and induced
-
D656862-1mlDS-7423 is a dual PI3K and mTOR inhibitor, with IC 50 values of 15.6 nM, 34.9 nM for PI3Kα and mTOR , respectively. DS-7423 possesses anti-tumor activity.In VitroDS-7423 increases TP53 expression, the level of p-TP53 on Ser-46, and induced
-
D650292-10mgDS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with IC 50 of 90 nMForm:SolidIC50&: Target:IC50: 90 nM (PTHR1).
-
D650292-5mgDS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with IC 50 of 90 nMForm:SolidIC50&: Target:IC50: 90 nM (PTHR1).
-
D650108-10mgDS12881479 is a potent and selective Mnk1 inhibitor with an IC 50 value of 21 nM. DS12881479 can be used in cancer research.Form:Solid.
-
D650108-5mgDS12881479 is a potent and selective Mnk1 inhibitor with an IC 50 value of 21 nM. DS12881479 can be used in cancer research.Form:Solid.
-
D647615-100mgDS18561882 is a highly potent, isozyme-selective methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) inhibitor with an IC 50 value of 0.0063 μM. DS18561882 also has inhibitory effect on MTHFD1 ( IC 50 =0.57 μM). DS18561882 exhibits a good oral
-
D647615-10mgDS18561882 is a highly potent, isozyme-selective methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) inhibitor with an IC 50 value of 0.0063 μM. DS18561882 also has inhibitory effect on MTHFD1 ( IC 50 =0.57 μM). DS18561882 exhibits a good oral
-
D647615-25mgDS18561882 is a highly potent, isozyme-selective methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) inhibitor with an IC 50 value of 0.0063 μM. DS18561882 also has inhibitory effect on MTHFD1 ( IC 50 =0.57 μM). DS18561882 exhibits a good oral